litlas
ログインアカウント作成

Nader Rifai

1986–2025 年に発表

206
論文数
93,460
被引用数
140
h 指数
206
i10 指数

被引用数

Nader Rifai の年別被引用数1945 年: 被引用 1 件1964 年: 被引用 4 件1976 年: 被引用 2 件1987 年: 被引用 3 件1988 年: 被引用 1 件1989 年: 被引用 2 件1991 年: 被引用 3 件1992 年: 被引用 4 件1993 年: 被引用 5 件1994 年: 被引用 2 件1995 年: 被引用 9 件1996 年: 被引用 11 件1997 年: 被引用 14 件1998 年: 被引用 26 件1999 年: 被引用 74 件2000 年: 被引用 167 件2001 年: 被引用 447 件2002 年: 被引用 728 件2003 年: 被引用 1,151 件2004 年: 被引用 1,289 件2005 年: 被引用 1,316 件2006 年: 被引用 1,478 件2007 年: 被引用 1,247 件2008 年: 被引用 1,348 件2009 年: 被引用 1,181 件2010 年: 被引用 1,035 件2011 年: 被引用 958 件2012 年: 被引用 853 件2013 年: 被引用 816 件2014 年: 被引用 638 件2015 年: 被引用 653 件2016 年: 被引用 621 件2017 年: 被引用 506 件2018 年: 被引用 548 件2019 年: 被引用 1,677 件2020 年: 被引用 1,675 件2021 年: 被引用 1,397 件2022 年: 被引用 1,092 件2023 年: 被引用 818 件2024 年: 被引用 1,254 件2025 年: 被引用 613 件2026 年: 被引用 46 件1946〜1963 年は被引用が無いため表示していません1965〜1975 年は被引用が無いため表示していません1977〜1986 年は被引用が無いため表示していません1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 8,117 件、この内訳の 28.9%イギリス: 引用元論文 2,125 件、この内訳の 7.6%中国: 引用元論文 1,420 件、この内訳の 5.1%イタリア: 引用元論文 1,302 件、この内訳の 4.6%ドイツ: 引用元論文 1,262 件、この内訳の 4.5%カナダ: 引用元論文 1,185 件、この内訳の 4.2%オーストラリア: 引用元論文 988 件、この内訳の 3.5%オランダ: 引用元論文 968 件、この内訳の 3.5%スペイン: 引用元論文 767 件、この内訳の 2.7%フランス: 引用元論文 756 件、この内訳の 2.7%日本: 引用元論文 704 件、この内訳の 2.5%スウェーデン: 引用元論文 650 件、この内訳の 2.3%
0%28.9%その他 27.9%

機関

分野

  • Medicine70.7%
  • Biochemistry, Genetics and Molecular Biology9.9%
  • Immunology and Microbiology3.5%
  • Nursing3.1%
  • Neuroscience2.9%
  • Psychology2.3%
  • その他7.6%

トピック

  • Adipokines, Inflammation, and Metabolic Diseases5.8%
  • Lipoproteins and Cardiovascular Health4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.8%
  • Nutritional Studies and Diet2.3%
  • Atherosclerosis and Cardiovascular Diseases2.2%
  • Inflammatory Biomarkers in Disease Prognosis1.4%
  • その他80.5%

共著者

全論文

検索で開く
  1. Markers of Inflammation and Cardiovascular Disease

    著者: Thomas A. Pearson, George A. Mensah, R. Wayne Alexander, Jeffrey L. Anderson, Richard O. Cannon, Michael H Criqui, Yazid Y. Fadl, Stephen P. Fortmann, Yuling Hong, Gary L. Myers, Nader Rifai, Sidney C. Smith, Kathryn A. Taubert, Russell P. Tracy, Frank Vinicor - Circulation 2003 被引用: 6,361

  2. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies

    著者: Patrick M. Bossuyt, Johannes B. Reitsma, David E. Bruns, Constantine Gatsonis, Paul Glasziou, Les Irwig, Jeroen G. Lijmer, David Moher, Drummond Rennie, Henrica C. W. de Vet, Herbert Y. Kressel, Nader Rifai, Robert Golub, Douglas G. Altman, Lotty Hooft, Daniël A. Korevaar, Jérémie F. Cohen, For the STARD Group - Radiology 2015 被引用: 1,305

  3. Developing a reporting guideline for artificial intelligence-centred diagnostic test accuracy studies: the STARD-AI protocol

    著者: Viknesh Sounderajah, Hutan Ashrafian, Robert Golub, Shravya Shetty, Jeffrey De Fauw, Lotty Hooft, Karel G.M. Moons, Gary S. Collins, David Moher, Patrick M. Bossuyt, Ara Darzi, Alan Karthikesalingam, Alastair K. Denniston, Bilal A. Mateen, Daniel Shu Wei Ting, Darren Treanor, Dominic King, Felix Greaves, Jonathan Godwin, Jonathan Pearson‐Stuttard, Leanne Harling, Matthew D. F. McInnes, Nader Rifai, Nenad Tomašev, Pasha Normahani, Penny Whiting, Ravi Aggarwal, Sebastian J. Vollmer, Sheraz R. Markar, Trishan Panch, Xiaoxuan Liu - BMJ Open 2021 被引用: 312

  4. C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

    著者: Paul M. Ridker, Charles H. Hennekens, Julie E. Buring, Nader Rifai - New England Journal of Medicine 2000 被引用: 5,857

  5. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies

    著者: Patrick M. Bossuyt, Johannes B. Reitsma, David E. Bruns, Constantine Gatsonis, Paul Glasziou, Les Irwig, Jeroen G. Lijmer, David Moher, Drummond Rennie, Henrica C. W. de Vet, Herbert Y. Kressel, Nader Rifai, Robert Golub, Douglas G. Altman, Lotty Hooft, Daniël A. Korevaar, Jérémie F. Cohen - BMJ 2015 被引用: 3,338

  6. Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women

    著者: Paul M. Ridker, M. Vinayaga Moorthy, Nancy R. Cook, Nader Rifai, I‐Min Lee, Julie E. Buring - New England Journal of Medicine 2024 被引用: 238

  7. Protein biomarker discovery and validation: the long and uncertain path to clinical utility

    著者: Nader Rifai, Michael A. Gillette, Steven A. Carr - Nature Biotechnology 2006 被引用: 1,845

  8. Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

    著者: Paul M. Ridker, Nader Rifai, Lynda Rose, Julie E. Buring, Nancy R. Cook - New England Journal of Medicine 2002 被引用: 3,608

  9. Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women

    著者: Paul M. Ridker, Julie E. Buring, Nader Rifai, Nancy R. Cook - JAMA 2007 被引用: 1,806

  10. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

    著者: Børge G. Nordestgaard, Anne Langsted, Samia Mora, Genovefa Kolovou, H Baum, Éric Bruckert, Gerald F. Watts, Grażyna Sypniewska, Olov Wiklund, Jan Borén, M. John Chapman, Christa M. Cobbaert, Olivier Descamps, Arnold von Eckardstein, Pia R. Kamstrup, Kari Pulkki, Florian Kronenberg, Alan T. Remaley, Nader Rifai, Emilio Ros, Michel R. Langlois - European Heart Journal 2016 被引用: 835

  11. Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men

    著者: Paul M. Ridker, Nader Rifai, Meir J. Stampfer, Charles H. Hennekens - Circulation 2000 被引用: 2,431

  12. C-Reactive Protein Levels and Outcomes after Statin Therapy

    著者: Paul M. Ridker, Christopher P. Cannon, David A. Morrow, Nader Rifai, Lynda M. Rose, Carolyn H. McCabe, Marc A. Pfeffer, Eugene Braunwald - New England Journal of Medicine 2005 被引用: 2,297

  13. Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis

    著者: Eri Kato, David A. Morrow, Jianping Guo, David D. Berg, Michael A. Blazing, Erin A. Bohula, Marc P. Bonaca, Christopher P. Cannon, James A. de Lemos, Robert P. Giugliano, Petr Jarolı́m, Tibor Kempf, L. Kristin Newby, Michelle L. O’Donoghue, Marc A. Pfeffer, Nader Rifai, Stephen D. Wiviott, Kai C. Wollert, Eugene Braunwald, Marc S. Sabatine - European Heart Journal 2022 被引用: 98

  14. Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk

    著者: Hans K. Meier-Ewert, Paul M. Ridker, Nader Rifai, Meredith M. Regan, Nick J. Price, David F. Dinges, Janet Mullington - Journal of the American College of Cardiology 2004 被引用: 1,199

  15. Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and Men

    著者: Eric L. Ding, Yiqing Song, JoAnn E. Manson, David J. Hunter, Cathy C. Lee, Nader Rifai, Julie E. Buring, J. Michael Gaziano, Simin Liu - New England Journal of Medicine 2009 被引用: 723

  16. Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy

    著者: Paul M. Ridker, Nader Rifai, Jean MacFadyen, Robert J. Glynn, Lixia Jiao, Philippe Gabríel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Jean‐Claude Tardif, Christie M. Ballantyne, R. Preston Mason, Deepak L. Bhatt - Circulation 2022 被引用: 125

  17. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction

    著者: Teresa T. Fung, Marjorie L. McCullough, P.K. Newby, JoAnn E. Manson, James B. Meigs, Nader Rifai, Walter C. Willett, Frank B. Hu - American Journal of Clinical Nutrition 2005 被引用: 839

  18. Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial

    著者: Paul M. Ridker, Lei Lei, Kausik K. Ray, Christie M. Ballantyne, Gary Bradwin, Nader Rifai - Journal of clinical lipidology 2023 被引用: 66

  19. C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events

    著者: Paul M. Ridker, Julie E. Buring, Nancy R. Cook, Nader Rifai - Circulation 2003 被引用: 2,291

  20. Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

    著者: Børge G. Nordestgaard, Michel R. Langlois, Anne Langsted, M. John Chapman, Kristin M. Aakre, H Baum, Jan Borén, Éric Bruckert, Alberico L. Catapano, Christa M. Cobbaert, Paul Collinson, Olivier Descamps, Christopher J. Duff, Arnold von Eckardstein, Angelika Hammerer‐Lercher, Pia R. Kamstrup, Genovefa Kolovou, Florian Kronenberg, Samia Mora, Kari Pulkki, Alan T. Remaley, Nader Rifai, Emilio Ros, Sanja Stanković, Ana Stavljenić-Rukavina, Grażyna Sypniewska, Gerald F. Watts, Olov Wiklund, Päivi Laitinen - Atherosclerosis 2019 被引用: 238

  21. Effect of Statin Therapy on C-Reactive Protein Levels

    著者: Michelle A. Albert, Ellie Danielson, Nader Rifai, Paul M. Ridker, for the PRINCE Investigators - JAMA 2001 被引用: 1,654

  22. Lipoprotein(a) and Risk of Type 2 Diabetes

    著者: Samia Mora, Pia R. Kamstrup, Nader Rifai, Børge G. Nordestgaard, Julie E. Buring, Paul M. Ridker - Clinical Chemistry 2010 被引用: 240

  23. Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial

    著者: Paul M. Ridker, Jean MacFadyen, Robert J. Glynn, Gary Bradwin, Ahmed Hasan, Nader Rifai - European Heart Journal 2020 被引用: 154

  24. Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women

    著者: Sandeep Bansal, Julie E. Buring, Nader Rifai, Samia Mora, Frank M. Sacks, Paul M. Ridker - JAMA 2007 被引用: 1,627